Bhutan vs Japan: Proportion of isolates with decreased susceptibility or resistance
Bhutan
1
in 2020
Japan
3.7
in 2020
Bhutan rank
8th
Japan rank
5th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- Japan
How they compare
Japan currently reports 3.7 against 1 in Bhutan, a difference of 2.7.
That makes Japan's figure about 3.7 times Bhutan's.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was Japan ahead.
Bhutan ranks 8th and Japan ranks 5th of 52 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 20.35 | 20.35 | Japan |
| 2010s | 1.74 | 16.01 | 14.27 | Japan |
| 2020s | 1 | 3.7 | 2.7 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or Japan?
- Japan, at 3.7 against 1 in Bhutan as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and Japan?
- 2.7, with Japan ahead.
- How many years of comparable data are there for Bhutan and Japan?
- 9 years are reported by both, from 2009 to 2020.
- How do Bhutan and Japan rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 8th and Japan ranks 5th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.